News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM L.A. McKeown May 16, 2021
News Daily News No Long-term CV Impact With Mild COVID-19, Two New Studies Reassure L.A. McKeown May 12, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Daily News Radial Superior to Femoral Access in Patients With Prior CABG Michael O'Riordan April 07, 2021
News Daily News VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients Todd Neale April 06, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key Michael O'Riordan March 16, 2021
News Daily News Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention Michael O'Riordan March 11, 2021
News Daily News Beyond Research, KCCQ Scores Can Help Predict Events Post-TAVI/TMVR Yael L. Maxwell February 25, 2021
News Daily News Single Troponin Test May Be Enough for Safe Discharge of Chest Pain Patients Todd Neale February 25, 2021
News Daily News Machine Learning ‘Sniffs’ Out Long QT Otherwise Unseen on ECG Yael L. Maxwell February 11, 2021
News Daily News Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access Michael O'Riordan February 05, 2021
News Daily News Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care Yael L. Maxwell January 26, 2021
News Daily News Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD Michael O'Riordan January 25, 2021
News Daily News Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution L.A. McKeown January 22, 2021
News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021